<DOC>
	<DOCNO>NCT02004509</DOCNO>
	<brief_summary>Introduction : Patients atrial fibrillation ( AF ) substantial risk stroke systemic embolism . Subclinical AF often suspect cause stroke patient . The detection asymptomatic AF episode challenge real rate occurrence episode remains unknown . The rate stroke high among patient receive pacemaker device detect subclinical episode rapid atrial rate , correlate electrocardiographically document AF . The net benefit anticoagulant treatment well establish patient clinical AF data anticoagulation subclinical AF set unknown . The aim study assess impact anticoagulant therapy subclinical AF , direct cardiac implantable electronic device ( CIED ) intensive monitoring , incidence stroke systemic embolism correlate AF episodes detect CIED thromboembolic event . Methods : This prospective , randomize , unicentric , parallel clinical study patient atrioventricular pacemaker , defibrillator cardiac resynchronization therapy device sinus rhythm CHADS2 score ( index risk stroke patient atrial fibrillation , range 0 6 ) â‰¥ 2 . Patients randomized intervention group - intensive monitoring arm ( Group I ) control group - routine schedule arm ( Group II ) 1:1 ratio . Time inclusion 24 month patient follow period 36 month . Group I patient submit device data collection every 2 month , Group II patient manage conventionally . Patients Group I episodes subclinical AF receive anticoagulant therapy , well patient clinical AF arm . Device data Group II patient analyze achieve primary endpoint . Primary endpoint : stroke systemic embolism . Secondary endpoint : subclinical AF rate , total mortality , cardiovascular mortality , myocardial infarction , cardiovascular hospitalization bleed rate . Expected outcome : It expect anticoagulation therapy subclinical AF direct CIED intensive monitoring reduce incidence stroke systemic embolism compare patient non-diagnosed subclinical AF .</brief_summary>
	<brief_title>SILENT - Subclinical AtrIal FibrilLation StrokE PreveNtion Trial</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Age &gt; = 18 year CHADS2 score &gt; =2 Sinus rhythm Cardiac Implantable Electronic Device Atrial fibrillation Severe heart valve disease Anticoagulation therapy Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>stroke</keyword>
	<keyword>pacemaker</keyword>
	<keyword>anticoagulant</keyword>
</DOC>